152 related articles for article (PubMed ID: 20591784)
1. [Pathogenesis of adrenocortical cancer].
Szabó D; Zsippai A; Bendes M; Tömböl Z; Szabó PM; Rácz K; Igaz P
Orv Hetil; 2010 Jul; 151(29):1163-70. PubMed ID: 20591784
[TBL] [Abstract][Full Text] [Related]
2. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
Haase M; Willenberg HS
Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
[TBL] [Abstract][Full Text] [Related]
3. Genetic aspects of adrenocortical tumours and hyperplasias.
Mazzuco TL; Durand J; Chapman A; Crespigio J; Bourdeau I
Clin Endocrinol (Oxf); 2012 Jul; 77(1):1-10. PubMed ID: 22471738
[TBL] [Abstract][Full Text] [Related]
4. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
Tissier F
Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
[TBL] [Abstract][Full Text] [Related]
5. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
7. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
Jouinot A; Bertherat J
Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
Bertherat J; Groussin L; Bertagna X
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
10. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract][Full Text] [Related]
11. Mutations in adrenocortical tumors.
Reincke M
Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways of human adrenocortical carcinoma - translating cell signalling knowledge into diagnostic and treatment options.
Szyszka P; Grossman AB; Diaz-Cano S; Sworczak K; Dworakowska D
Endokrynol Pol; 2016; 67(4):427-50. PubMed ID: 27387247
[TBL] [Abstract][Full Text] [Related]
13. Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
Kalkan E; Waguespack SG
Front Horm Res; 2013; 41():166-81. PubMed ID: 23652677
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of benign adrenocortical tumors.
Vezzosi D; Bertherat J; Groussin L
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):893-905. PubMed ID: 21115158
[TBL] [Abstract][Full Text] [Related]
15. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
16. Molecular adrenocortical tumourigenesis.
Reincke M; Beuschlein F; Slawik M; Borm K
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():63-8. PubMed ID: 11281372
[TBL] [Abstract][Full Text] [Related]
17. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical tumorigenesis: Lessons from genetics.
Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor system on adrenocortical tumorigenesis.
Ribeiro TC; Latronico AC
Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]